Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 1998, p. 2004-2013, Vol. 36, No. 7
Department of Molecular Biology and Genetics,
Quest Diagnostics, Inc., Baltimore, Maryland 21227
Received 24 October 1997/Returned for modification 2 April
1998/Accepted 15 April 1998
The C18-carboxypropylbetaine (CB-18) procedure for
processing respiratory specimens for the detection of mycobacteria was shown to provide significant increases in sensitivity by smear and
culture. However, the procedure also produced increased contamination, a loss in liquid culture sensitivity, and a reduction in smear specificity. Because of these observations, the toxicity of CB-18 and
the nature of the contamination were characterized. Preincubation in 1 mM CB-18 impacted viability in a time-dependent fashion, but the
magnitude of the loss was species and isolate dependent. Mycobacterium tuberculosis isolates were the most
susceptible, losing 20 to 30% of the CFU within 30 min and 30 to 60%
after 3 h, whereas Mycobacterium avium and
Mycobacterium fortuitum isolates were unaffected by CB-18.
In liquid culture, when the concentration of CB-18 exceeded 5 µg/ml,
there was an impact on growth characteristics for the most susceptible
M. tuberculosis isolate. In contrast, M. fortuitum isolates were able to grow in 100 µg of CB-18 per ml.
In liquid culture, the deleterious effects of CB-18 were enhanced in
the presence of antibiotics, whereas growth on solid media was not
similarly affected. Supplementation of the resuspension buffer with
0.15% lecithin alleviated toxicity. Initial attempts to modify the
CB-18 procedure to control contamination incorporated acids or alkalis;
however, losses in culture sensitivity occurred. Studies to identify
these contaminants led to the development of a sediment resuspension
buffer that contained lytic enzymes to combat contamination and
lecithin to alleviate toxicity. This formulation included lysozyme,
zymolyase, and Cytophaga and Trichoderma extracts and was seen to reduce contamination to acceptable levels (<5%).
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Processing Respiratory Specimens with
C18-Carboxypropylbetaine: Development of a Sediment
Resuspension Buffer That Contains Lytic Enzymes To Reduce the
Contamination Rate and Lecithin To Alleviate Toxicity

and
*
Corresponding author. Mailing address: Quest
Diagnostics, Inc., Department of Molecular Biology and Genetics, 1901 Sulphur Spring Rd., Baltimore, MD 21227. Phone: (410) 536-1524. Fax:
(410) 536-1633. E-mail: thornton{at}msmail.mml.com.
Present address: Becton Dickinson Advanced Diagnostics, Sparks, MD
21152.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»